Clinical trial
Choice of the Optimal Method for Treatment of Acute Thrombophlebitis of the Varicose Great Saphenous Vein: Comparison of Endovenous Laser Ablation and Conservative Approach
NCT05001776 is registered in ClinicalTrials.gov with National Medical Research Center for Therapy and Preventive Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Choice of the Optimal Method for Treatment of Acute Thrombophlebitis of the Varicose Great Saphenous Vein: Comparison of Endovenous Laser Ablation and Conservative Approach
- Lead sponsor
- National Medical Research Center for Therapy and Preventive Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 16, 2021
- Completion date
- December 1, 2023
- Enrollment
- 105 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endovenous laser ablation, superficial vein thrombosis